Related Experiment Video
Updated: Oct 5, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Adrenal functional reserve in the full spectrum of chronic kidney disease
René Rodríguez-Gutiérrez1,2, José G González-González1,2, Alberto Martínez-Rodríguez3
1Endocrinology Department.
Insights
Cortisol levels rise in early chronic kidney disease (CKD) as kidney function declines. This study found no adrenal insufficiency (AI) in CKD patients, suggesting routine AI screening is unnecessary.
Area of Science:
- Endocrinology
- Nephrology
- Internal Medicine
Background:
- Altered cortisol levels are linked to mortality and reduced quality of life in chronic kidney disease (CKD) patients.
- Adrenal response to adrenocorticotropic hormone (ACTH) stimulation has not been well-evaluated in stages 3-5 CKD, with or without renal replacement therapy (RRT).
Purpose of the Study:
- To evaluate adrenal function in patients diagnosed with chronic kidney disease (CKD).
Main Methods:
- A low-dose cosyntropin (synthetic ACTH) stimulation test was administered to adult CKD patients.
- Serum cortisol levels were measured at baseline, 30 minutes, and 60 minutes post-stimulation.
Main Results:
- Sixty participants with stages 3-5 CKD (with/without RRT) were included; none exhibited adrenal insufficiency (AI).
- A significant negative correlation was found between glomerular filtration rate (GFR) and cortisol levels at baseline, 30 minutes, and 60 minutes post-ACTH stimulation (r: -0.39 to -0.4, p ≤ 0.004).
Conclusions:
- Cortisol levels increase in early CKD stages as GFR decreases.
- Systematic screening for adrenal insufficiency (AI) is not deemed necessary for patients with chronic kidney disease (CKD).
Background:
Altered cortisol levels have been associated with an increase in mortality and a decrease in health-related quality of life in patients with chronic kidney disease (CKD); however, adrenal response to adrenocorticotropic hormone (ACTH) stimulation test has not been evaluated in patients with stage 3a to 5 CKD with and without renal replacement therapy (RRT).
Objective:
To evaluate adrenal function in patients with CKD.
Materials And Methods:
Adults with CKD underwent a low-dose cosyntropin stimulation test (1 µg synthetic ACTH), with serum cortisol levels being measured at 0, +30 and +60 minutes post-test.
Results:
Sixty participants with stage 3, 4 and 5 CKD (with and without RRT) were included. None of the patients had adrenal insufficiency (AI). The correlation observed between cortisol concentration at baseline and 30 minutes and 1 hour after stimulation and glomerular filtration rate (GFR) was negative and statistically significant (r: -0.39 [p = 0.002], r: -0.363 [p = 0.004], r: -0.4 [p = 0.002], respectively).
Conclusion:
Since CKD early stages, cortisol levels increase as GFR decreases. Therefore, we conclude that systematic screening for AI is not necessary in CKD patients.
More Related Videos
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury III: Clinical Manifestations

